SNS Funds Dymista® for Allergic Rhinitis



Rhinitis is the most common allergic disease in Spain, affecting about 20% of the population.

SNS is funding Dymista® at a retail price of EUR 15.61, which will increase access to this first-line treatment for controlling nasal and ocular symptoms in patients with allergic rhinitis.Allergic rhinitis is a pathology that causes inflammation … + read more


More than 50% of people with allergic rhinitis have asthma, but most don’t know it

Symptoms of allergic asthma must be identified before starting treatment with an inhaler (if they have been prescribed) or seeing a pulmonologist for a proper diagnosis. + read more

Atopic Diseases Associated with Dementia Risk

This risk increases with the number of allergic comorbidities and affects Alzheimer’s disease and vascular dementia. + read more

How to improve the quality of life of patients with nasal cavity disease

A roundtable session at the SEORL-CCC Congress explored in depth the different scales for measuring this in allergic rhinitis, septal and turbinate surgery, or endoscopic sinus surgery. + read more

Children with hay fever have poorer asthma control

Children with hay fever have poorer asthma control because hay fever can cause runny nose, sneezing, congestion and sinus pressure. + read more

Vitamin D protects nasal epithelium from infection

A study identifies the cellular mechanism by which vitamin D enhances defense against bacterial and viral microorganisms. + read more

EMA assesses the effect of pseudoephedrine drugs on the risk of cerebral ischemia

Pseudoephedrine is taken by mouth, alone or in combination with other medications, to treat nasal congestion (nasal congestion) caused by colds, flu, or allergies. + read more

Source link

Leave a Comment